| Tara Turken, MS, CCC-SLP | |
|
1660 Stafford Ave, Bristol, CT 06010-2571 | |
| (860) 583-8483 | |
| Not Available |
| Full Name | Tara Turken |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1660 Stafford Ave, Bristol, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316125925 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 003495 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tara Turken, MS, CCC-SLP Po Box 18, Avon, CT 06001-0018 Ph: (860) 508-4586 | Tara Turken, MS, CCC-SLP 1660 Stafford Ave, Bristol, CT 06010-2571 Ph: (860) 583-8483 |
News Archive
"In the developing world, an estimated 215 million women who want to delay or avoid their next pregnancy cannot exercise this right as they lack modern contraceptives, resulting in unintended pregnancies, unsafe abortions and more than 100,000 maternal deaths," UNFPA Executive Director Babatunde Osotimehin writes in this Huffington Post "Global Motherhood" blog post.
Roughly 1 in 4 women having breast conserving surgery (BCS) return to the surgical suite for further resection because of cancerous tissue left behind due to unclear margins. Investigators at the Optics in Medicine Lab at Dartmouth's Thayer School of Engineering and Norris Cotton Cancer Center, led by Brian W. Pogue, PhD and Keith Paulsen PhD, with first author and PhD candidate David M. McClatchy III, devised a novel approach to perform near infrared (NIR) optical measurements of resected breast tissue after the margins have had their traditional marking by the surgeon to preserve information about their orientation for potential follow-up surgeries.
Santarus, Inc., a specialty biopharmaceutical company, today announced that new data from open-label studies evaluating the efficacy and safety of the investigational drug RHUCIN for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema were presented at the 7th C1 Inhibitor Deficiency Workshop on May 20 - 22, 2011 in Budapest, Hungary.
A new research tool will allow University of Oregon scientists to replicate an extreme range of environmental conditions in their quest to test and understand the human body's response to everyday stresses.
In his mind, Basil Hubbard can already picture a new world of therapeutic treatments for millions of patients just over the horizon. It's a future in which diseases like muscular dystrophy, cystic fibrosis and many others are treated permanently through the science of genome engineering.
› Verified 2 days ago
Christine Xanthoudakis, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 N Main St, Bristol, CT 06010 Phone: 860-584-3400 | |
Katherine Tilley Sullivan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 440 N Main St, Bristol, CT 06010 Phone: 860-893-1977 | |
Miss Sara Marie Tye, M.S., CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 145 Fox Den Rd, Bristol, CT 06010 Phone: 860-716-0715 | |
Learn Play Grow Speech Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 143 Sherwood Rd, Bristol, CT 06010 Phone: 860-999-1487 | |
Septimiu Cozmuta, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 23 Fair St, Bristol, CT 06010 Phone: 860-589-2923 | |
Lynn Ann Litwinczyk, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 124 Hopmeadow Rd, Bristol, CT 06010 Phone: 860-582-0546 |